bevacizumab-adcd

CHEBI:CHEBI_754399

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2627659
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
dosage_form
INJECTION, SOLUTION
route
INTRAVENOUS
marketing_start_date
20230403
package_marketing_start_date
20230403
marketing_category
BLA
labeler_name
CELLTRION USA, Inc.
manufacturer_name
CELLTRION USA, Inc.
active_ingredient_strength
100 mg/4mL
nui
N0000178291
pharm_class_epc
Vascular Endothelial Growth Factor Inhibitor [EPC]
pharm_class
Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
pharm_class_moa
Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
active_ingredient_name
BEVACIZUMAB
unii
2S9ZZM9Q9V
generic_name
bevacizumab-adcd
brand_name
Vegzelma
brand_name_base
Vegzelma
product_ndc
72606-011
application_number
BLA761268
spl_id
d58b28c8-9a47-4869-92c5-a55895ec1605
package_ndc
72606-011-10
package_description
10 VIAL, SINGLE-USE in 1 CARTON (72606-011-10) / 4 mL in 1 VIAL, SINGLE-USE
spl_set_id
4cdcccda-7b9a-49d0-ac50-f4605a3c0ebe
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class